The vertebroplasty and kyphoplasty market has seen considerable growth due to a variety of factors.
• The market size for vertebroplasty & kyphoplasty has seen a substantial increase in recent times. The projection is that the market value will rise from $0.97 billion in 2024 to $1.04 billion in 2025, expanding at a Compound Annual Growth Rate (CAGR) of 6.9%.
Factors such as an aging demographic, prevalence of osteoporosis, progression in minimally invasive procedures, heightened awareness and diagnosis, escalating lifestyle-related elements, and an increasing load on healthcare systems can explain the growth observed in the historic period.
The vertebroplasty and kyphoplasty market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for vertebroplasty & kyphoplasty is anticipated to experience substantial growth in the coming years. It is expected to expand to $1.28 billion by 2029 at a compound annual growth rate (CAGR) of 5.5%.
This projected growth during the forecast period is due to factors such as an enhanced emphasis on geriatric care, improvement of biocompatible bone cement, increased preference for outpatient procedures, focus on value-driven healthcare, and the rise in the elderly population. Notable trends in the forecast period encompass research and innovation in spinal interventions, further development of ambulatory surgical centers, advancements in bone cement technology, procedural technological improvements, and healthcare cost management in the face of reimbursement challenges.
Increasing instances of spine-related injuries due to sports activities are predicted to accelerate the vertebroplasty and kyphoplasty markets' expansion. These sporting spinal injuries comprise vertebral compression fractures, spondylolisthesis, and herniated discs that call for less invasive treatments including vertebroplasty and kyphoplasty procedures. Such procedures include the infusion of bone cement into injured vertebrae. As per the New Zealand Spinal Trust's data in November 2023, the incidence rate in New Zealand has grown modestly from 41 per million in 2021 to 45 per million, comparable with 2020’s rate of 44 per million. In 2022, men represented 74% of traumatic spinal cord injury cases while women constituted 33% of non-traumatic spinal cord injury cases. Hence, the increase of sports-related spinal injuries is foreseen to bolster the growth of vertebroplasty and kyphoplasty market. According to the report, the escalating number of elderly people worldwide is projected to fuel the growth of the vertebroplasty and kyphoplasty market. This population, typically 65 years and above, require special care owing to their unique health conditions resulting from aging. The treatments of vertebroplasty and kyphoplasty help alleviate pain and stabilize vertebral compression fractures, improving mobility and overall life quality for seniors. As per the World Health Organization in October 2022, it's projected that by 2030, one-sixth of the global population will be aged 60 and above, growing to 2.1 billion by 2050. Consequently, the increasing elderly population emerges as a key driver for the expansion of the vertebroplasty and kyphoplasty market.
The vertebroplasty and kyphoplasty market covered in this report is segmented –
1) By Product Type: Kyphoplasty Devices, Vertebroplasty Devices
2) By Surgery Type: Vertebroplastic Surgery, Kyphoplastic Surgery
3) By End User: Hospitals, Ambulatory Surgical Centers
Subsegments:
1) By Kyphoplasty Devices: Balloon Kyphoplasty Devices, Inflation Devices, Vertebral Restoration Devices
2) By Vertebroplasty Devices: Bone Cement Delivery Systems, Cannulas and Needles
3) By Spinal Biopsy Devices: Spinal Biopsy Devices
Leading companies in the vertebroplasty and kyphoplasty market are focusing on strategic alliances to supply a unipedicular balloon catheter for treating compression fractures of the vertebrae. These strategic alliances are characterized by firms utilizing one another's strengths and resources to realize shared benefits and success. For example, in June 2024, Ireland-based medical technology firm Medtronic Plc formed a partnership with US-based medical device firm Merit Medical Systems Inc. This partnership aims to create a unipedicular, steerable balloon catheter for treating vertebral compression fractures (VCF) in the United States. Building upon their existing collaboration, Merit already supplies Medtronic's Kyphon Xpander Inflation Syringes used in balloon kyphoplasty procedures. Engineered for controlled, accurate, and targeted cavity creation during vertebral augmentation, the Kyphon KyphoFlex will accompany this unipedicular solution to the existing bipedicular balloon kyphoplasty provided by Medtronic, increasing versatility and choices for medical practitioners.
Major companies operating in the vertebroplasty and kyphoplasty market report are:
• Cardinal Health
• Johnson and Johnson (DePuy Synthes)
• Medtronic Plc.
• Stryker Corporation
• GS Solutions Inc.
• Lepu Medical Technology (Beijing)Co.Ltd.
• Merit Medical Systems Inc.
• Globus Medical Inc.
• Alphatec Spine Inc.
• Rontis Corporation
• Spectrum Plastics Group.
• SOMATEX Medical Technologies GmbH
• Zavation LLC
• MJ Surgical
• Benvenue Medical
• Joimax GmbH
• Laurane Medical LLC
• Spine Wave Inc.
• G21 S.r.l.
• BM Korea Co. Ltd.
• Biopsybell Medical
• Teknimed
• Joline GmbH And Co. KG
• SCW Medicath Ltd.
• Stöckli Medical AG
• Jiangsu ChangMei Medtech Co.Ltd.
• IZI Medical Products
North America was the largest region in the vertebroplasty and kyphoplasty market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vertebroplasty and kyphoplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.